In the current issue:
-
ABL1, SRC and Other Non-Receptor Protein Tyrosine Kinases as New Targets for Specific Anticancer Therapy
Klener Pavel et al. -
EGFR Tyrosine Kinase Inhibitors as a Targeted Therapy for Bronchioloalveolar Carcinoma of the Lung: a Case Report of a Clinically Prompt and Intensive Response and Literature Review
Svoboda Marek et al. -
Changes in Target Volumes Definition by Using MRI for Prostate Bed Radiotherapy Planning – Preliminary Results
Šefrová Jana et al.
Reviews
Klin Onkol 2010; 23(4): 203-209.
Keywords: non-receptor tyrosine kinases, SRC, BCR-ABL1, TKI, imatinib, nilotinib, dasatinib, CML, solid tumours, prostate cancer, bone metastases
Authors: Klener Pavel, Klener jr Pavel2010-08-15:ABL1, SRC and Other Non-Receptor Protein Tyrosine Kinases as New Targets for Specific Anticancer Therapy
Keywords: non-receptor tyrosine kinases, SRC, BCR-ABL1, TKI, imatinib, nilotinib, dasatinib, CML, solid tumours, prostate cancer, bone metastases
Authors: Klener Pavel, Klener jr Pavel2010-08-15:ABL1, SRC and Other Non-Receptor Protein Tyrosine Kinases as New Targets for Specific Anticancer Therapy
Klin Onkol 2010; 23(4): 210-217.
Keywords: Merkel cell carcinoma, diagnostic imaging, etiology, cancer staging, cell cycle, Merkel cell polyomavirus, therapy, prognosis
Authors: Krejčí Karel, Zadražil J., Tichý Tomáš, Horák P., Ciferská H., Hodulová M., Zezulová Michaela, Zlevorová Miloslava2010-08-15:Merkel Cell Skin Carcinoma
Keywords: Merkel cell carcinoma, diagnostic imaging, etiology, cancer staging, cell cycle, Merkel cell polyomavirus, therapy, prognosis
Authors: Krejčí Karel, Zadražil J., Tichý Tomáš, Horák P., Ciferská H., Hodulová M., Zezulová Michaela, Zlevorová Miloslava2010-08-15:Merkel Cell Skin Carcinoma
Klin Onkol 2010; 23(4): 218-223.
Keywords: head and neck cancer, biological markers, prognosis, targeted therapy
Authors: Smilek Pavel2010-08-15:Molecular Predictors in Head and Neck Tumours
Keywords: head and neck cancer, biological markers, prognosis, targeted therapy
Authors: Smilek Pavel2010-08-15:Molecular Predictors in Head and Neck Tumours
Klin Onkol 2010; 23(4): 224-230.
Keywords: lung cancer, bronchioloalveolar carcinoma, EGFR gene, K-ras gene, erlotinib, gefitinib, targeted therapy, prediction
Authors: Svoboda Marek, Fabián Pavel, Slabý Ondřej, Staňková (Skalová) Martina, Lakomý Radek, Němeček Radim, Vyzula Rostislav2010-08-15:EGFR Tyrosine Kinase Inhibitors as a Targeted Therapy for Bronchioloalveolar Carcinoma of the Lung: a Case Report of a Clinically Prompt and Intensive Response and Literature Review
Keywords: lung cancer, bronchioloalveolar carcinoma, EGFR gene, K-ras gene, erlotinib, gefitinib, targeted therapy, prediction
Authors: Svoboda Marek, Fabián Pavel, Slabý Ondřej, Staňková (Skalová) Martina, Lakomý Radek, Němeček Radim, Vyzula Rostislav2010-08-15:EGFR Tyrosine Kinase Inhibitors as a Targeted Therapy for Bronchioloalveolar Carcinoma of the Lung: a Case Report of a Clinically Prompt and Intensive Response and Literature Review
Klin Onkol 2010; 23(4): 231-241.
Keywords: bile duct neoplasms, cholangiocarcinoma, gallbladder cancer, palliative treatment
Authors: Tuček Štěpán, Tomášek Jiří, Halámková Jana, Kiss Igor, Andrašina Tomáš, Hemmelová Beáta, Adámková Krákorová Dagmar, Vyzula Rostislav2010-08-15:Bile Duct Malignancies
Keywords: bile duct neoplasms, cholangiocarcinoma, gallbladder cancer, palliative treatment
Authors: Tuček Štěpán, Tomášek Jiří, Halámková Jana, Kiss Igor, Andrašina Tomáš, Hemmelová Beáta, Adámková Krákorová Dagmar, Vyzula Rostislav2010-08-15:Bile Duct Malignancies
Klin Onkol 2010; 23(4): 242-244.
Keywords: multiple myeloma, bortezomib, allogeneic transplantation, hematopoietic stem cell transplantation
Authors: Vokurka Samuel2010-08-15:Bortezomib in Multiple Myeloma Patients after Allogeneic Stem Cell Transplantation
Keywords: multiple myeloma, bortezomib, allogeneic transplantation, hematopoietic stem cell transplantation
Authors: Vokurka Samuel2010-08-15:Bortezomib in Multiple Myeloma Patients after Allogeneic Stem Cell Transplantation
Original articles
Klin Onkol 2010; 23(4): 245-255.
Keywords: nephroblastoma, late effects, cancer survivorship, children, adolescents, prevention, second cancer
Authors: Radvanský Jiří, Slabý Kryštof, Radvanská Jitka, Mališ Josef, Eckschlager Tomáš, Šulc J., Šafářová M., Kolský A., Procházka Martin, Gilík J.2010-08-15:Late Effect of Treatment of Nephroblastoma in Patients Treated in 1980–2001 in a Single Centre
Keywords: nephroblastoma, late effects, cancer survivorship, children, adolescents, prevention, second cancer
Authors: Radvanský Jiří, Slabý Kryštof, Radvanská Jitka, Mališ Josef, Eckschlager Tomáš, Šulc J., Šafářová M., Kolský A., Procházka Martin, Gilík J.2010-08-15:Late Effect of Treatment of Nephroblastoma in Patients Treated in 1980–2001 in a Single Centre
Klin Onkol 2010; 23(4): 256-263.
Keywords: prostate cancer, radiotherapy, radiotherapy planning, magnetic resonance imaging, clinical target volume
Authors: Šefrová Jana, Paluska Petr, Odrážka Karel, Bělobrádek Z., Hoffmann Petr, Prošvic Petr, Broďák Miloš, Louda Miroslav, Pleskačová (Mačingová) Zuzana, Vošmik Milan2010-08-15:Changes in Target Volumes Definition by Using MRI for Prostate Bed Radiotherapy Planning – Preliminary Results
Keywords: prostate cancer, radiotherapy, radiotherapy planning, magnetic resonance imaging, clinical target volume
Authors: Šefrová Jana, Paluska Petr, Odrážka Karel, Bělobrádek Z., Hoffmann Petr, Prošvic Petr, Broďák Miloš, Louda Miroslav, Pleskačová (Mačingová) Zuzana, Vošmik Milan2010-08-15:Changes in Target Volumes Definition by Using MRI for Prostate Bed Radiotherapy Planning – Preliminary Results
Case report
Klin Onkol 2010; 23(4): 264-268.
Keywords: breast cancer, male, treatment
Authors: Drahokoupilová M.2010-08-15:Metastatic Breast Cancer in 28 Years Old Man
Keywords: breast cancer, male, treatment
Authors: Drahokoupilová M.2010-08-15:Metastatic Breast Cancer in 28 Years Old Man
